Lowering LDL-C with bempedoic acid in patients with complex clinical profiles: European experience and local cases
03 Jun 2026
byProf. Vivencio Barrios, Ramón y Cajal University Hospital, Spain; Dr. Walter Wai-Chee Chen, Specialist in Cardiology, Private practice, Hong Kong
LDL-cholesterol (LDL-C) is the main driver of atherosclerotic cardiovascular disease (ASCVD), yet LDL-C control in high-risk patients remains far from optimal. At an industry-sponsored meeting, Professor Vivencio Barrios from Ramón y Cajal University Hospital, Spain, discussed the role of bempedoic acid in managing complex patients, while Dr Walter Wai-Chee Chen, Specialist in Cardiology in private practice in Hong Kong, shared local cases of bempedoic acid use in patients with mild-to-moderate chronic kidney disease (CKD) and complex clinical profiles.